Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD).
作者信息
MacDonald T T
出版信息
Clin Exp Immunol. 1995 Dec;102(3):445-7. doi: 10.1111/j.1365-2249.1995.tb03835.x.
Abstract
摘要
相似文献
1
Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD).炎症性肠病（IBD）中对肠道菌群耐受性的破坏。
Clin Exp Immunol. 1995 Dec;102(3):445-7. doi: 10.1111/j.1365-2249.1995.tb03835.x.
2
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD).机体对肠道常驻菌群存在耐受性，但在活动性炎症性肠病（IBD）中这种耐受性会被打破。
Clin Exp Immunol. 1995 Dec;102(3):448-55. doi: 10.1111/j.1365-2249.1995.tb03836.x.
3
Layers of mutualism with commensal bacteria protect us from intestinal inflammation.与共生细菌的互利共生层保护我们免受肠道炎症的侵害。
Gut. 2006 Feb;55(2):276-84. doi: 10.1136/gut.2004.054098.
4
Intestinal flora and mucosal immune responses.肠道菌群与黏膜免疫反应。
Int J Med Microbiol. 2003 Apr;293(1):77-86. doi: 10.1078/1438-4221-00246.
5
The pathogenic role of intestinal flora in IBD and colon cancer.肠道菌群在炎症性肠病和结肠癌中的致病作用。
Curr Drug Targets. 2008 May;9(5):395-403. doi: 10.2174/138945008784221125.
6
Gut biofilm forming bacteria in inflammatory bowel disease.炎症性肠病中的肠道生物膜形成细菌。
Microb Pathog. 2017 Nov;112:5-14. doi: 10.1016/j.micpath.2017.09.041. Epub 2017 Sep 20.
7
Immunoglobulin coating of faecal bacteria in inflammatory bowel disease.炎症性肠病中粪便细菌的免疫球蛋白包被
Eur J Gastroenterol Hepatol. 2004 Jul;16(7):669-74. doi: 10.1097/01.meg.0000108346.41221.19.
8
Is diet a factor in the pathogenesis of IBD?饮食是炎症性肠病发病机制中的一个因素吗？
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S35-6. doi: 10.1002/ibd.20547.
9
Role of commensal enteric bacteria in the pathogenesis of immune-mediated intestinal inflammation: lessons from animal models and implications for translational research.共生肠道细菌在免疫介导的肠道炎症发病机制中的作用：来自动物模型的经验教训及对转化研究的启示。
J Pediatr Gastroenterol Nutr. 2005 Apr;40 Suppl 1:S30-1. doi: 10.1097/00005176-200504001-00018.
10
Helminths and Intestinal Flora Team Up to Improve Gut Health.蠕虫与肠道菌群协同作用以改善肠道健康。
Trends Parasitol. 2016 Sep;32(9):664-666. doi: 10.1016/j.pt.2016.05.006. Epub 2016 May 24.
引用本文的文献
1
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis.关于绿原酸在疾病治疗中的治疗功效、临床试验和新型给药系统的最新进展，特别强调溃疡性结肠炎。
Curr Pharm Des. 2024;30(6):420-439. doi: 10.2174/0113816128295753240129074035.
2
As a Versatile Vehicle for Tolerogenic Immunotherapy.作为耐受性免疫疗法的通用载体。
Front Immunol. 2018 Jan 17;8:1961. doi: 10.3389/fimmu.2017.01961. eCollection 2017.
3
Hsp65-Producing Prevents Inflammatory Intestinal Disease in Mice by IL-10- and TLR2-Dependent Pathways.产生Hsp65通过IL-10和TLR2依赖性途径预防小鼠炎症性肠病。
Front Immunol. 2017 Jan 30;8:30. doi: 10.3389/fimmu.2017.00030. eCollection 2017.
4
Elemental diet and the nutritional treatment of Crohn's disease.要素饮食与克罗恩病的营养治疗
Gastroenterol Hepatol Bed Bench. 2015 Winter;8(1):4-5.
5
Deficiency of invariant NK T cells in Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎中不变自然杀伤T细胞的缺陷。
Dig Dis Sci. 2007 Jun;52(6):1415-22. doi: 10.1007/s10620-006-9261-7. Epub 2007 Apr 10.
6
Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora.川崎病可能是遗传易感性儿童对正常环境菌群变体的一种超敏免疫反应。
Med Hypotheses. 2007;69(3):642-51. doi: 10.1016/j.mehy.2006.12.051. Epub 2007 Mar 6.
7
Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.患有活动性炎症性肠病的患者缺乏未成熟的外周血浆细胞样和髓样树突状细胞。
Gut. 2005 Feb;54(2):228-36. doi: 10.1136/gut.2004.040360.
8
Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.多药耐药1a基因缺陷型转基因小鼠自发性结肠炎的宏观、微观及生化特征
Br J Pharmacol. 2004 Nov;143(5):590-8. doi: 10.1038/sj.bjp.0705982. Epub 2004 Oct 4.
9
Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease.正常细菌和细菌产物对单核细胞/巨噬细胞的激活作用：对克罗恩病中上皮功能改变的影响
Am J Pathol. 2001 Mar;158(3):1101-9. doi: 10.1016/S0002-9440(10)64057-6.
10
Experimental colitis induced by trinitrobenzenesulfonic acid: an ultrastructural and histochemical study.三硝基苯磺酸诱导的实验性结肠炎：超微结构和组织化学研究
Dig Dis Sci. 1999 Dec;44(12):2523-9. doi: 10.1023/a:1026651408998.
本文引用的文献
1
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD).机体对肠道常驻菌群存在耐受性，但在活动性炎症性肠病（IBD）中这种耐受性会被打破。
Clin Exp Immunol. 1995 Dec;102(3):448-55. doi: 10.1111/j.1365-2249.1995.tb03836.x.
2
Interleukin-10-deficient mice develop chronic enterocolitis.白细胞介素-10缺陷型小鼠会患上慢性小肠结肠炎。
Cell. 1993 Oct 22;75(2):263-74. doi: 10.1016/0092-8674(93)80068-p.
3
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.白细胞介素-2基因缺失小鼠中的溃疡性结肠炎样疾病
Cell. 1993 Oct 22;75(2):253-61. doi: 10.1016/0092-8674(93)80067-o.
4
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.甲硝唑治疗预防回肠切除术后克罗恩病复发的对照试验。
Gastroenterology. 1995 Jun;108(6):1617-21. doi: 10.1016/0016-5085(95)90121-3.
5
Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats.大鼠慢性肉芽肿性结肠炎模型中的黏膜损伤与炎症
Gastroenterology. 1993 Mar;104(3):759-71. doi: 10.1016/0016-5085(93)91011-6.
6
The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease.
Clin Immunol Immunopathol. 1994 Jun;71(3):303-8. doi: 10.1006/clin.1994.1090.
7
The faecal flora of patients with Crohn's disease.克罗恩病患者的粪便菌群。
J Hyg (Lond). 1981 Aug;87(1):1-12. doi: 10.1017/s0022172400069187.
8
Mechanisms confining indigenous bacteria to the gastrointestinal tract.将本土细菌限制在胃肠道内的机制。
Am J Clin Nutr. 1980 Nov;33(11 Suppl):2472-84. doi: 10.1093/ajcn/33.11.2472.
9
The microbiota of the gastrointestinal tract.胃肠道的微生物群。
Gastroenterology. 1966 Nov;51(5):868-74.
10
Electron microscopy in Crohn's disease.克罗恩病的电子显微镜检查
Gut. 1971 Jul;12(7):509-18. doi: 10.1136/gut.12.7.509.
Zotero 插件